🚀 Today marks an extraordinary milestone at Cellino! We are thrilled to announce that our team has been awarded up to $25M in funding from the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services (HHS). This funding will drive the development of our ultra-scalable, autonomous, cassette-based advanced biomanufacturing technology for personalized regenerative medicine. Cellino’s NEBULA (NExt-generation Biomanufacturing ULtra-scalable Approach) project is the first project funded by the Scalable Solutions Mission Office under the ARPA-H Open Broad Agency Announcement. With ARPA-H’s support, Cellino will build a cassette-based biomanufacturing technology capable of scaling the production of personalized induced pluripotent stem cells at hospitals nationwide to develop curative medicines for a range of chronic conditions for an increasingly diverse and aging U.S. patient population. We are excited to move closer to making “Your Cells, Your Cure™” a reality for millions of patients. We are thrilled about this opportunity to advance our goal of making patient-specific stem cell-derived therapies available for broad patient audiences. 📄 Read the full release: https://bwnews.pr/4gfrjlb #ARPAH #Biotech #AI #MachineLearning #PersonalizedMedicine #Collaboration #Innovation #RegenerativeMedicine #BiotechBreakthroughs #CellinoBio #YourCellsYourCure #Biomanufacturing
Cellino
Biotechnology Research
Cambridge, Massachusetts 16,510 followers
Your Cells, Your Cure™
About us
Cellino is building a scalable, automated biomanufacturing system for potentially curative personalized cell therapies. Cellino’s vision is to enable healthier lives worldwide with personalized treatments derived from induced pluripotent stem cells (iPSCs), which can serve as the basis for therapies for a host of chronic degenerative diseases, including vision loss and Parkinson's disease.
- Website
-
http://www.cellinobio.com
External link for Cellino
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Privately Held
- Founded
- 2017
Locations
-
Primary
750 Main Street
Cambridge, Massachusetts 02139, US
Employees at Cellino
Updates
-
Our “CELLebrate Your Cells” Campaign begins next week, and voting opens in just 2 days. Explore a range of #celltypes and cast your vote for the one you'd most like to see made available through on-demand manufacturing. Your vote can help inform the innovation of cell and tissue production and bring us closer to a world where personalized medicines are accessible to all. 🚀 🗳️ Be the first to vote on Sunday, October 6 at 8 AM EDT. 🗓️ Mark your calendars and follow Cellino for our latest updates. 📢 Spread the word to help shape the future of personalized #regenmed with us! #Cellino #Biotech #LifeSciences #Biomanufacturing #CellTypes #TissueEngineering #RegenerativeMedicine #Innovation #PersonalizedMedicine #HealthEquity #FutureOfHealthcare #YourCellsYourCure #CELLebrateYourCells
-
🚀 What an incredible Day 2 at #ISSCR2024 in #Copenhagen! We extend our gratitude to the International Society for Stem Cell Research for hosting such a dynamic gathering. Marinna Madrid, PhD, our Co-Founder & Chief Product Officer, delivered an insightful presentation on "Optical Bioprocessing," showcasing how our #AI- and laser-based biomanufacturing technology is scaling personalized iPSC-based regenerative medicines. We appreciate everyone who attended the session and are excited for the future that the global community is building together! It has also been a pleasure for Cellino team members, including Nabiha Saklayen, our CEO & Co-Founder, and Rebecca "Becky" Kusko, PhD, Head of Corporate Strategy and Affairs, to connect with global leaders and discuss the potential of iPSC-derived therapies to bring potential cures to patients. 🌐 🤝 #CellinoBio #StemLeaders #Biotech #BiotechInnovation #Collaboration #Therapeutics #ResearchAndDevelopment #PersonalizedMedicine #RegenMed #YourCellsYourCure #Conference #ISSCR
-
🚀 Marinna Madrid, PhD, our Co-Founder & Chief Product Officer, will be speaking at this year's #CGMesa24 from October 7-9 in #Phoenix, Arizona! She will join other industry leaders on the panel, "Next Generation CGT Process Development and Manufacturing - Improving Efficiencies and Reducing Cost of Goods," on Tuesday, October 8, from 4:15 PM – 5:15 PM PDT, with moderator Jennifer MacDonald, M.D., Chief Operating Officer, Advanced Regenerative Manufacturing Institute (ARMI). 🧬 Panelists include: Marinna Madrid, PhD, Co-Founder & Chief Product Officer, Cellino Philippe Cronet, General Manager of WACKER Kenneth Harris, Chief Strategy and AI Officer of OmniaBio Rick Modi, CEO of Affinia Therapeutics 🗓️ Request a meeting through ParteringOne to connect with our team and learn more about Cellino’s scalable #biomanufacturing tech stack here: 👉 https://bit.ly/3TVtb9k Alliance for Regenerative Medicine #AllianceRM #Biotech #AI #MachineLearning #Collaboration #Innovation #RegenMed #Therapeutics #PersonalizedMedicine #YourCellsYourCure #CellinoBio
-
💡 If you could print personalized cells, tissues, or organs on demand, what would you make first? We want to hear your thoughts! 💬 Our “CELLebrate Your Cells” Campaign launches next week! We’ll feature a range of #celltypes, and you get to vote on which you would most like to see made available through on-demand manufacturing. Your vote can drive innovative solutions to scale cell and tissue production and help build a future where personalized medicines are accessible to all. 🚀 🗳️ Be the first to vote on Sunday, October 6 at 8 AM EDT. 🗓️ Mark your calendars and follow Cellino for our latest updates. 📢 Spread the word to help shape the future of personalized #regenmed with us! At Cellino, we are committed to advancing our automated #biomanufacturing tech stack for autologous cell- and tissue-based therapies. This multidisciplinary approach offers tailored treatments addressing key challenges in scaling and efficiency to accelerate health outcomes and provide hope to countless patients. #Cellino #Biotech #LifeSciences #Biomanufacturing #CellTypes #TissueEngineering #RegenerativeMedicine #Innovation #PersonalizedMedicine #HealthEquity #FutureOfHealthcare #YourCellsYourCure #CELLebrateYourCells
-
🗓️ Come join us at #CGMesa24 on Tuesday, October 8 at 11:45 AM MST! Our CEO & Co-Founder, Nabiha Saklayen, will discuss how Cellino’s ultra-scalable, autonomous #biomanufacturing technology is accelerating the development of personalized regenerative medicines. Learn how our innovations aim to solve scalability and #healthequity by advancing curative treatments for a range of chronic conditions. 🤝 Contact us to request a meeting with Nabiha or another Cellino team member during the meeting through the partnering portal here: meetingonthemesa.com Alliance for Regenerative Medicine #AllianceRM #Biotech #AI #MachineLearning #Collaboration #Innovation #RegenMed #Therapeutics #PersonalizedMedicine #YourCellsYourCure #CellinoBio
-
🎤 It was a privilege to have Michael C., Automation Engineer at Cellino present at #Benchtalk2024, where he shared groundbreaking insights on “Adaptive Biomanufacturing to Scale Autologous Cell Therapy.” We were also honored to have Jesse Mulcahy, our Director and Head of Automation, attend and engage with industry leaders. A big thank you to Benchling for bringing the global community of R&D scientists and technology leaders together. We’re proud to be part of the conversation, sharing how our advancements in #labautomation are enabling scalable solutions for personalized regenerative medicines! 🌟
🎤 It was fantastic to see Michael C. representing Cellino at Benchtalk 2024! He delivered a compelling presentation on **“Adaptive Biomanufacturing to Scale Autologous Cell Therapy”**, sharing insights from top labs on achieving end-to-end automation. 💡 Michael discussed innovative strategies to tackle key challenges in automation, connectivity, and data accessibility – all critical components for the future of biomanufacturing. His expertise and passion for advancing lab automation truly shined through. 🌟 If you’re looking to explore automation best practices or have questions about Cellino's approach, don’t hesitate to reach out! #Benchtalk2024 #CellinoBio #LabAutomation #Biomanufacturing #EndToEndAutomation #ScientificDiscovery
-
🚨 🚀 Exciting Announcement! Mark your calendars for the launch of Cellino’s “CELLebrate Your Cells" Campaign! From October 6 - October 13, you’ll have the opportunity to explore the possibilities of personalized regenerative medicine and #castyourvote for the #celltype you would want to see printed on-demand first. We'll spotlight various cell types to demonstrate the transformative potential of scalable biomanufacturing. Our goal is to gather diverse perspectives on which cell-based tissues should be prioritized to improve patient outcomes. Each vote encourages the development of novel modalities and contributes to a collective vision of a healthier future, where personalized therapies are accessible to patients. 🧫✨ 🗳 Voting launches on Sunday, October 6 at 8 AM EDT. Personalized regenerative medicine is a seismic shift in healthcare, moving away from the traditional disease treatment paradigm. This autologous approach has the potential to treat chronic conditions and aims to cure patients with their individualized therapies. 🌟 Stay tuned for updates as we prepare to announce voting. 🔔 Follow Cellino and turn on post notifications so you'll be the first to vote! 🔁 Repost and share to help shape the future of personalized regenerative medicine with us! #Cellino #Biotech #LifeSciences #Biomanufacturing #CellTypes #RegenerativeMedicine #Innovation #PersonalizedMedicine #HealthEquity #FutureOfHealthcare #YourCellsYourCure #CELLebrateYourCells
-
🧬 The Hanson Wade Group’s 4th Annual iPSC Drug Development & Manufacturing Conference in #Boston is in full swing! Our Principal Product Manager, Bar Makovoz, PhD, will be presenting on “An Advanced Biomanufacturing Technology to Scale Production of Autologous iPSC-Based Cell Therapies,” at 11:45 AM EDT on Thursday, October 3. Join us for this session on Conference Day 2, part of the Manufacturing & Analytical Development track. 🔬 Key topics to be highlighted include: 🔷 Automated cell culture, imaging, liquid handling, and cell removal: driven by AI-based in-process characterization and decision making 🔷 Closed cassette-based GMP system in early development 🔷 60 unique and clonal iPSC lines generated from a diversity of donors, with demonstrated successful differentiation in the hands of collaborators We’re excited to contribute to the conversation around the evolution of iPSC-based cell therapies and how these advancements will shape the future of personalized regenerative medicine. 🚀 👉 See the full agenda here: bit.ly/4eM74Kl #HansonWadeGroup #RegenMed #Biotech #DrugDevelopment #Therapeutics #AI #AIinHealthcare #MachineLearning #PersonalizedMedicine #YourCellsYourCure #CellinoBio
-
We’re honored to have been recognized by Governor Healey during her keynote address at #WMIF24, hosted by Mass General Brigham, where she highlighted Cellino’s award from Advanced Research Projects Agency for Health (ARPA-H). This recognition highlights the hard work and dedication of our entire team, and we extend our gratitude to #ARPA-H Director Renee Wegrzyn and MA Secretary of Economic Development Yvonne Hao for their support of innovation in Kendall Square. 🌟🚀
Honored by Governor Healey's keynote recognition of Cellino and our Advanced Research Projects Agency for Health (ARPA-H) award at #WMIF24 hosted by Mass General Brigham. This acknowledgment means the world to me and the entire Cellino team! It was inspiring to hear from two superstars, ARPA-H Director Renee Wegrzyn, and MA Secretary Yvonne Hao, about the visionary programs ARPA-H is driving in close partnership with Massachusetts. We are thrilled to have the opportunity to build Nebula as an ARPA-H performer in Kendall Square, the heart of innovation. Massachusetts has been instrumental in my journey from physicist to founder, and I’m proud to call it home. I’m excited about the opportunities ahead and look forward to collaborating to drive groundbreaking innovation! 🌟 #Cellino #Innovation #ARPAH #KendallSquare #Boston #Massachusetts